Newman Dignan & Sheerar Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $408K | Buy |
16,944
+15
| +0.1% | +$392 | 0.08% | 140 |
|
|
2026
Q1 | $475K | Sell |
16,929
-569
| -3% | -$15.1K | 0.1% | 126 |
|
|
2025
Q4 | $436K | Buy |
17,498
+1,870
| +12% | +$47.2K | 0.09% | 127 |
|
|
2025
Q3 | $398K | Sell |
15,628
-17
| -0.1% | -$420 | 0.09% | 131 |
|
|
2025
Q2 | $379K | Sell |
15,645
-1,568
| -9% | -$36.6K | 0.09% | 134 |
|
|
2025
Q1 | $436K | Sell |
17,213
-222
| -1% | -$5.81K | 0.12% | 110 |
|
|
2024
Q4 | $463K | Sell |
17,435
-706
| -4% | -$19.1K | 0.12% | 112 |
|
|
2024
Q3 | $524K | Sell |
18,141
-1,340
| -7% | -$39.1K | 0.13% | 112 |
|
|
2024
Q2 | $545K | Sell |
19,481
-730
| -4% | -$20.1K | 0.14% | 108 |
|
|
2024
Q1 | $561K | Sell |
20,211
-3,337
| -14% | -$92.6K | 0.15% | 110 |
|
|
2023
Q4 | $678K | Sell |
23,548
-7,778
| -25% | -$235K | 0.2% | 100 |
|
|
2023
Q3 | $1.04M | Sell |
31,326
-1,416
| -4% | -$50.1K | 0.34% | 74 |
|
|
2023
Q2 | $1.2M | Buy |
32,742
+9
| +0% | +$350 | 0.37% | 71 |
|
|
2023
Q1 | $1.34M | Sell |
32,733
-91
| -0.3% | -$3.93K | 0.43% | 67 |
|
|
2022
Q4 | $1.68M | Sell |
32,824
-692
| -2% | -$33.2K | 0.56% | 55 |
|
|
2022
Q3 | $1.47K | Buy |
33,516
+271
| +0.8% | +$13.2K | 0.23% | 58 |
|
|
2022
Q2 | $1.74M | Sell |
33,245
-285
| -0.8% | -$14.5K | 0.59% | 52 |
|
|
2022
Q1 | $1.74K | Sell |
33,530
-246
| -0.7% | -$12.8K | 0.33% | 53 |
|
|
2021
Q4 | $1.99M | Buy |
33,776
+3
| +0% | +$149 | 0.6% | 46 |
|
|
2021
Q3 | $1.45M | Sell |
33,773
-149
| -0.4% | -$6.6K | 0.42% | 57 |
|
|
2021
Q2 | $1.33M | Buy |
33,922
+3,297
| +11% | +$128K | 0.45% | 61 |
|
|
2021
Q1 | $1.11M | Sell |
30,625
-2,027
| -6% | -$72K | 0.4% | 69 |
|
|
2020
Q4 | $1.2K | Sell |
32,652
-1,755
| -5% | -$64.4K | 0.19% | 61 |
|
|
2020
Q3 | $1.2M | Buy |
34,407
+527
| +2% | +$18.5K | 0.5% | 54 |
|
|
2020
Q2 | $1.25M | Buy |
33,880
+1,856
| +6% | +$63.1K | 0.54% | 51 |
|
|
2020
Q1 | $1.09M | Sell |
32,024
-782
| -2% | -$26.6K | 0.57% | 45 |
|
|
2019
Q4 | $1.22K | Buy |
32,806
+1,107
| +3% | +$39.4K | 0.13% | 58 |
|
|
2019
Q3 | $1.08M | Sell |
31,699
-12,337
| -28% | -$449K | 0.51% | 54 |
|
|
2019
Q2 | $1.81K | Sell |
44,036
-713
| -2% | -$28.3K | 0.05% | 31 |
|
|
2019
Q1 | $1.8M | Sell |
44,749
-194
| -0.4% | -$7.77K | 0.72% | 33 |
|
|
2018
Q4 | $1.86K | Buy |
44,943
+601
| +1% | +$24.9K | 0.16% | 37 |
|
|
2018
Q3 | $1.89M | Buy |
44,342
+128
| +0.3% | +$4.93K | 0.83% | 37 |
|
|
2018
Q2 | $1.52K | Sell |
44,214
-977
| -2% | -$33.4K | 0.1% | 38 |
|
|
2018
Q1 | $1.56M | Sell |
45,191
-2,726
| -6% | -$93.7K | 0.79% | 37 |
|
|
2017
Q4 | $1.65M | Buy |
47,917
+406
| +0.9% | +$13.8K | 0.82% | 36 |
|
|
2017
Q3 | $1.61M | Buy |
47,511
+15
| +0% | +$482 | 0.86% | 32 |
|
|
2017
Q2 | $1.51M | Buy |
47,496
+2,807
| +6% | +$88.5K | 0.84% | 32 |
|
|
2017
Q1 | $1.45K | Buy |
44,689
+3,153
| +8% | +$99.4K | 0.64% | 36 |
|
|
2016
Q4 | $1.28M | Buy |
41,536
+528
| +1% | +$16.1K | 0.78% | 37 |
|
|
2016
Q3 | $1.32M | Buy |
41,008
+5,663
| +16% | +$189K | 0.83% | 32 |
|
|
2016
Q2 | $1.18M | Buy |
35,345
+2,373
| +7% | +$75.7K | 0.74% | 39 |
|
|
2016
Q1 | $927K | Buy |
32,972
+16,955
| +106% | +$484K | 0.67% | 41 |
|
|
2015
Q4 | $491K | Hold |
16,017
| – | – | 0.35% | 81 |
|
|
2015
Q3 | $477K | Sell |
16,017
-442
| -3% | -$14.2K | 0.31% | 75 |
|
|
2015
Q2 | $524K | Buy |
16,459
+395
| +2% | +$12.9K | 0.38% | 71 |
|
|
2015
Q1 | $530K | Sell |
16,064
-105
| -0.6% | -$3.34K | 0.38% | 76 |
|
|
2014
Q4 | $478 | Hold |
16,169
| – | – | 0.29% | 83 |
|
|
2014
Q3 | $455K | Buy |
16,169
+403
| +3% | +$11.3K | 0.34% | 82 |
|
|
2014
Q2 | $444 | Sell |
15,766
-5,797
| -27% | -$165K | 0.25% | 88 |
|
|
2014
Q1 | $657K | Buy |
21,563
+211
| +1% | +$6.29K | 0.47% | 69 |
|
|
2013
Q4 | $621 | Buy |
21,352
+401
| +2% | +$11.7K | 0.03% | 72 |
|
|
2013
Q3 | $571K | Buy |
20,951
+316
| +2% | +$8.6K | 0.44% | 72 |
|
|
2013
Q2 | $548 | Buy |
+20,635
| New | +$570K | 0.04% | 69 |
|
Other funds holding PFE
AIM
SLAM
CWP
Newman Dignan & Sheerar Inc's PFE Position: Q2 2026 in Review
Newman Dignan & Sheerar Inc increased its Pfizer (PFE) stake by 0.09% in Q2 2026, buying an estimated $392 and bringing the position to 16,944 shares worth $408K. The position accounts for 0.08% of the portfolio, ranked #140.
Newman Dignan & Sheerar Inc first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.99M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Newman Dignan & Sheerar Inc held 16,944 shares of Pfizer worth $408K as of Q2 2026.
- Newman Dignan & Sheerar Inc bought 15 Pfizer shares in Q2 2026, an estimated $392.
- Pfizer made up 0.08% of Newman Dignan & Sheerar Inc's portfolio in Q2 2026, its #140 holding.
- Newman Dignan & Sheerar Inc first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Newman Dignan & Sheerar Inc's Pfizer position peaked at $1.99M in Q4 2021.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2026, filed 14 Jul 2026.